Discovery of the Highly Selective and Potent STAT3 Inhibitor for Pancreatic Cancer Treatment

Discovery of the Highly Selective and Potent STAT3 Inhibitor for Pancreatic Cancer Treatment

Bibliographic Details
Main Authors:	Huang Chen, Aiwu Bian, Wenbo Zhou, Ying Miao, Jiangnan Ye, Jiahui Li, Peng He, Qiansen Zhang, Yue Sun, Zhenliang Sun, Chaowen Ti, Yihua Chen, Zhengfang Yi, Mingyao Liu
Format:	Article
Language:	English
Published:	American Chemical Society 2024-02-01
Series:	ACS Central Science
Online Access:	https://doi.org/10.1021/acscentsci.3c01440

Similar Items

A potent and selective small molecule inhibitor of myoferlin attenuates colorectal cancer progression
by: Yuan He, et al.
Published: (2021-02-01)

Preclinical characterization of WB737, a potent and selective STAT3 inhibitor, in natural killer/T‐cell lymphoma
by: Yali Wang, et al.
Published: (2023-08-01)

Discovery of potent STAT3 inhibitors using structure-based virtual screening, molecular dynamic simulation, and biological evaluation
by: Weifeng Liu, et al.
Published: (2023-11-01)

Discovery of a potent and highly selective inhibitor of SIRT6 against pancreatic cancer metastasis in vivo
by: Xinyuan Xu, et al.
Published: (2024-03-01)

Discovery of potent histone deacetylase inhibitors with modified phenanthridine caps
by: Wenli Fan, et al.
Published: (2021-01-01)

Discovery of novel and potent CDK8 inhibitors for the treatment of acute myeloid leukaemia
by: Zhuoying Chen, et al.
Published: (2024-12-01)

Discovery of potent and noncovalent KRASG12D inhibitors: Structure-based virtual screening and biological evaluation
by: Yuting Wang, et al.
Published: (2022-12-01)

Discovery of Quercetin and Its Analogs as Potent OXA-48 Beta-Lactamase Inhibitors
by: Yuejuan Zhang, et al.
Published: (2022-06-01)

Discovery of Highly Potent Small Molecule Pan-Coronavirus Fusion Inhibitors
by: Francesca Curreli, et al.
Published: (2023-04-01)

Discovery of Amide-Functionalized Benzimidazolium Salts as Potent α-Glucosidase Inhibitors
by: Imran Ahmad Khan, et al.
Published: (2021-08-01)

Discovery of WD-890: A novel allosteric TYK2 inhibitor for the treatment of multiple autoimmune diseases
by: Zhiqin Fang, et al.
Published: (2023-11-01)

Hierarchical And Fragment Based Virtual Screening Approaches In The Discovery Of Potent Acetylcholinesterase Inhibitor
by: Muhammad, Erma Fatiha
Published: (2022)

Discovery of a potent and selective DDR1 receptor tyrosine kinase inhibitor.
by: Kim, H, et al.
Published: (2013)

Discovery of Oxazol-2-amine Derivatives as Potent Novel FLT3 Inhibitors
by: Hyo Jeong Kim, et al.
Published: (2020-11-01)

Discovery Potent of Thiazolidinedione Derivatives as Antioxidant, α-Amylase Inhibitor, and Antidiabetic Agent
by: Manal Y. Sameeh, et al.
Published: (2021-12-01)

Discovery of Novel Biphenyl Carboxylic Acid Derivatives as Potent URAT1 Inhibitors
by: Xianxin Hou, et al.
Published: (2023-11-01)

Discovery and characterization of naturally occurring chalcones as potent inhibitors of bile salt hydrolases
by: Chun-Yu Li, et al.
Published: (2022-05-01)

Functional metagenomics-guided discovery of potent Cas9 inhibitors in the human microbiome
by: Kevin J Forsberg, et al.
Published: (2019-09-01)

DISCOVERY OF TRIKETONE-QUINOXALINE HYBRIDS AS POTENT HPPD INHIBITORS USING STRUCTURE-BASED DRUG DESIGN
by: Baifeng ZHENG, Yaochao YAN, Can FU, Guangyi HUANG, Long ZHAO, Qiong CHEN, Renyu QU, Guangfu YANG
Published: (2022-03-01)

STAT3 Inhibitors: A Novel Insight for Anticancer Therapy of Pancreatic Cancer
by: Xin Li, et al.
Published: (2022-10-01)

Discovery of a novel NUAK1 inhibitor against pancreatic cancer
by: Myeong-Seong Seo, et al.
Published: (2022-08-01)

Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors
by: Boby, ML, et al.
Published: (2023)

Stat3 inhibitor Stattic exhibits potent antitumor activity and induces chemo- and radio-sensitivity in nasopharyngeal carcinoma.
by: Yunbao Pan, et al.
Published: (2013-01-01)

Correction to Discovery of a Potent and Selective DDR1 Receptor Tyrosine Kinase Inhibitor.
by: Kim, H, et al.
Published: (2014)

New potent dual inhibitors of CK2 and Pim kinases: discovery and structural insights.
by: López-Ramos, M, et al.
Published: (2010)

New potent dual inhibitors of CK2 and Pim kinases: discovery and structural insights.
by: López-Ramos, M, et al.
Published: (2010)

Discovery of Novel <i>N</i>-Acylhydrazone Derivatives as Potent Inhibitors of Sirtuin-1
by: Victoria V. Lipson, et al.
Published: (2024-04-01)

Discovery of the first-in-class potent and isoform-selective human carbonic anhydrase III inhibitors
by: Simone Giovannuzzi, et al.
Published: (2023-12-01)

Discovery of Sulforaphane as a Potent BACE1 Inhibitor Based on Kinetics and Computational Studies
by: Kumju Youn, et al.
Published: (2020-10-01)

Discovery of YS-363 as a highly potent, selective, and orally eﬃcacious EGFR inhibitor
by: Pengxing He, et al.
Published: (2023-11-01)

Generative deep learning enables the discovery of a potent and selective RIPK1 inhibitor
by: Yueshan Li, et al.
Published: (2022-11-01)

Discovery of a potent olaparib–chlorambucil hybrid inhibitor of PARP1 for the treatment of cancer
by: Hongyu Qin, et al.
Published: (2023-01-01)

Discovery of BAR502, as potent steroidal antagonist of leukemia inhibitory factor receptor for the treatment of pancreatic adenocarcinoma
by: Cristina Di Giorgio, et al.
Published: (2023-03-01)

Discovery of IHMT-337 as a potent irreversible EZH2 inhibitor targeting CDK4 transcription for malignancies
by: Husheng Mei, et al.
Published: (2023-01-01)

Discovery of potent tubulin inhibitors targeting the colchicine binding site via structure-based lead optimization and antitumor evaluation
by: Wei Liu, et al.
Published: (2023-12-01)

Discovery of a Novel Nav1.7 Inhibitor From Cyriopagopus albostriatus Venom With Potent Analgesic Efficacy
by: Yunxiao Zhang, et al.
Published: (2018-10-01)

Discovery of a potent dual SLK/STK10 inhibitor based on a maleimide scaffold
by: Serafim, RAM, et al.
Published: (2021)

The Discovery of Potent SHP2 Inhibitors with Anti-Proliferative Activity in Breast Cancer Cell Lines
by: Rose Ghemrawi, et al.
Published: (2022-04-01)

Molecular Drug Discovery of Single Ginsenoside Compounds as a Potent Bruton’s Tyrosine Kinase Inhibitor
by: Keun Woo Lee, et al.
Published: (2020-04-01)

Discovery of novel sulfonamide substituted indolylarylsulfones as potent HIV-1 inhibitors with better safety profiles
by: Shenghua Gao, et al.
Published: (2023-06-01)